Mark A. Demitrack
2020
In 2020, Mark A. Demitrack earned a total compensation of $1.6M as SVP and Chief Medical Officer at Trevena.
Compensation breakdown
| Non-Equity Incentive Plan | $257,600 |
|---|---|
| Option Awards | $455,950 |
| Salary | $456,667 |
| Stock Awards | $388,575 |
| Other | $11,400 |
| Total | $1,570,192 |
Demitrack received $456.7K in salary, accounting for 29% of the total pay in 2020.
Demitrack also received $257.6K in non-equity incentive plan, $456K in option awards, $388.6K in stock awards and $11.4K in other compensation.
Rankings
In 2020, Mark A. Demitrack's compensation ranked 6,639th out of 13,090 executives tracked by ExecPay. In other words, Demitrack earned more than 49.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,639 out of 13,090 | 49th |
Division Manufacturing | 2,759 out of 5,621 | 51st |
Major group Chemicals And Allied Products | 1,113 out of 2,254 | 51st |
Industry group Drugs | 963 out of 1,954 | 51st |
Industry Pharmaceutical Preparations | 722 out of 1,459 | 51st |
Source: SEC filing on May 9, 2022.
Demitrack's colleagues
We found two more compensation records of executives who worked with Mark A. Demitrack at Trevena in 2020.